Points of View

Novartis partners with Microsoft to build AI solutions—showing pharma firms why they must look to partnerships for success

Dec 23, 2019 Josh Matthews


Pharmas executives and artificial intelligence (AI) project leaders will undoubtedly have noticed the partnership between Microsoft and Novartis to leverage AI throughout the industry ecosystem and value chainThe competition to realize AIs potential in pharma is already fierce—modeling disease, drug discoveryand diagnosisbefore considering the challenges that the industrygrappling with: siloed functions and data, cultural barriers, and ongoing operational transformations. If youre late to the AI game in pharmadont panic, but the time to act is now. Iyoure swift, you will finplenty of potential partners with expertise out there and plenty of value propositions to realize by tackling the industrys most pressing challenges.  


Sign in or register an account to access HFS' Content

Sign In

Create an account

Enter a phone number
Select the newsletter(s) to which you wish to subscribe.